Pomerantz LLP announces that a class action lawsuit has been filed againstNovo Nordisk A/S(“Novo Nordisk” or the “Company”)(NYSE: NVO).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor646-581-9980,(or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg
The class action concerns whetherNovo Nordisk and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
You haveuntil September 30, 2025to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquiredNovo Nordisk securities during the Class Period. A copy of the Complaint can be obtained atwww.pomerantzlaw.com.
[Click here for information about joining the class action]
On July 29, 2025, Novo Nordisk significantly lowered its sales outlook for 2025, citing the impact of increased competition in the markets for its drugs Ozempic and Wegovy.
On this news, Novo Nordisk's American Depositary Receipt (“ADR”) price fell $15.06 per ADR, or 21.83%, to close at $53.94 per ADR on July 29, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. Seewww.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980ext. 7980
https://c212.net/c/img/favicon.png?sn=DC46076&sd=2025-08-06
View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-novo-nordisk-as-of-class-action-lawsuit-and-upcoming-deadlines—nvo-302523713.html
SOURCE Pomerantz LLP
https://rt.newswire.ca/rt.gif?NewsItemId=DC46076&Transmission_Id=202508061840PR_NEWS_USPR_____DC46076&DateId=20250806